Functional gastrointestinal disorders in patients with familial Mediterranean fever

Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disease characterised by recurrent episodes of fever and polyserositis. To date, insufficient data regarding the prevalence of functional gastrointestinal disorders such as irritable bowel syndrome (IBS) and functional dyspepsia (FD) have been reported in patients with FMF. This study aimed to determine the prevalence of functional gastrointestinal disorders in patients with FMF.

[1]  T. Kutlu,et al.  The Incidence of Irritable Bowel Syndrome in Children Using the Rome III Criteria and the Effect of Trimebutine Treatment , 2013, Journal of neurogastroenterology and motility.

[2]  N. Manek,et al.  Prevalence and Risk Factors of Gastrointestinal Disorders in Patients with Rheumatoid Arthritis: Results from a Population-Based Survey in Olmsted County, Minnesota , 2011, Gastroenterology research and practice.

[3]  W. Al-Daraji,et al.  Gastric Changes Following Colchicine Therapy in Patients with FMF , 2009, Digestive Diseases and Sciences.

[4]  W. Chey,et al.  An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome , 2008, The American Journal of Gastroenterology.

[5]  W. Al-Daraji,et al.  RETRACTED ARTICLE: Gastric Changes Following Colchicine Therapy in Patients with FMF , 2008, Digestive Diseases and Sciences.

[6]  M. Lidar,et al.  Familial Mediterranean fever: clinical, molecular and management advancements. , 2007, The Netherlands journal of medicine.

[7]  S. Kiraz,et al.  Plasma and platelet serotonin levels in familial Mediterranean fever. , 2007, Clinical and experimental rheumatology.

[8]  D. Booth,et al.  Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. , 2006, Rheumatology.

[9]  P. Moayyedi,et al.  American gastroenterological association technical review on the evaluation of dyspepsia. , 2005, Gastroenterology.

[10]  Gulzar Singh,et al.  Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  A. Bakkaloğlu,et al.  Familial Mediterranean Fever (FMF) in Turkey: Results of a Nationwide Multicenter Study , 2005, Medicine.

[12]  A. Mor,et al.  Abdominal and digestive system associations of familial Mediterranean fever , 2003, American Journal of Gastroenterology.

[13]  M. Camilleri,et al.  Functional gastroduodenal disorders , 1999, Gut.

[14]  R. Davis,et al.  Colchicine Is an Effective Treatment for Patients with Chronic Constipation (An Open-Label Trial) , 1997, Digestive Diseases and Sciences.

[15]  E. Ebert.  Gastrointestinal and hepatic manifestations of Sjogren syndrome. , 2012, Journal of clinical gastroenterology.

[16]  N. Talley.  Increased Frequency of Gastrointestinal Symptoms in Patients with Fibromyalgia and Associated Factors: A Comparative Study , 2010 .

[17]  S. U. Kaymak,et al.  Selective serotonin reuptake inhibitors reduce the attack frequency in familial mediterranean Fever. , 2007, The Tohoku journal of experimental medicine.